News
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
Hims & Hers continues to deliver strong revenue growth. Meanwhile, the company surprised investors by offering a long-term ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Hims & Hers ( HIMS 19.03%) stock soared 18.2% in trading on Tuesday after the company reported first-quarter revenue growth ...
A post-earnings rally in Hims & Hers Health Inc. has turned co-founder and Chief Executive Officer Andrew Dudum into a weight ...
Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.
Here are the latest rating downgrades by Seeking Alpha analysts: British American Tobacco (NYSE:BTI). Hold to sell by Michael ...
The FDA has received reports of erectile dysfunction, anxiety, and more after using topical finasteride, a popular hair loss medication. Experts say the medication is still safe for many, but you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results